“Budget Impact Analysis of the Use of Daclatasvir in Italy for the Treatment of Hepatitis C Virus (HCV) Genotype 3 Patients”. Farmeconomia. Health Economics and Therapeutic Pathways 17, no. 1 (March 31, 2016): 7–12. Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/1225.